Jose Baselga

Jose Baselga, MD, PhD: AACR Highlights 2012
May
17
2012

Dr. Jose Baselga highlights exciting studies at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jose Baselga, MD, PhD is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard Medical School. The Group Room at the American […]

Read More
Jose Baselga, MD, PhD: Pi3 Kinase Inhibitor Update
May
17
2012

Dr. Jose Baselga gives an Pi3 Kinase Inhibitor update¬† for breast cancer patients at the American Association for Cancer Research (AACR) Annual 2012 meeting in Chicago. Jose Baselga, MD, PhD is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard Medical […]

Read More
Jose Baselga, MD, PhD: BOLERO-2 Findings Confirm Efficacy of Everolimus Plus Exemestane
Jan
13
2012

  Dr. Jose Baselga discusses the exciting data for the HER2-negative breast cancer patient — the BOLERO-2 trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard […]

Read More
Jose Baselga, MD, PhD: CLEOPATRA Pertuzumab Trial Increases Progression-Free Survival
Jan
13
2012

  Dr. Jose Baselga discusses the exciting data for the HER2-positive breast cancer patient — the CLEOPATRA trial released at the CTRC-AACR 34th Annual San Antonio Breast Cancer Symposium. Dr. Baselga is the Chief of the Division of Hematology/Oncology, Associate Director of the Massachusetts General Hospital Cancer Center and a Professor, Department of Medicine, Harvard […]

Read More